{"title":"雌激素受体亚型在催乳素瘤中的表达及其与肿瘤生物学行为的关系。","authors":"Chu Zhong Li, S. Gui, Xu-yi Zong, Ya Zhuo Zhang","doi":"10.3967/bes2015.113","DOIUrl":null,"url":null,"abstract":"Dopamine agonists (DA) are a first-line therapy for prolactinomas (PA). However, nearly 10% of prolactinomas do not respond to DA therapy. A considerable number of studies have shown that estrogen plays an important role in the development of prolactinomas. However, the expression of estrogen receptors (ER) in prolactinomas has not been fully explored. Accordingly, we examined the levels of ESR1 and its subtypes Δ5-Del-ESR1 and ESR2 mRNA in prolactinomas. In the present study, we found that ESR1 mRNA levels were significantly lower in women of childbearing age group compared to men (P","PeriodicalId":9108,"journal":{"name":"Biomedical and environmental sciences : BES","volume":"67 1","pages":"820-2"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":"{\"title\":\"The Expression of Estrogen Receptor Subtypes in Prolactinomas and Their Relationship to Tumor Biological Behavior.\",\"authors\":\"Chu Zhong Li, S. Gui, Xu-yi Zong, Ya Zhuo Zhang\",\"doi\":\"10.3967/bes2015.113\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dopamine agonists (DA) are a first-line therapy for prolactinomas (PA). However, nearly 10% of prolactinomas do not respond to DA therapy. A considerable number of studies have shown that estrogen plays an important role in the development of prolactinomas. However, the expression of estrogen receptors (ER) in prolactinomas has not been fully explored. Accordingly, we examined the levels of ESR1 and its subtypes Δ5-Del-ESR1 and ESR2 mRNA in prolactinomas. In the present study, we found that ESR1 mRNA levels were significantly lower in women of childbearing age group compared to men (P\",\"PeriodicalId\":9108,\"journal\":{\"name\":\"Biomedical and environmental sciences : BES\",\"volume\":\"67 1\",\"pages\":\"820-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical and environmental sciences : BES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3967/bes2015.113\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical and environmental sciences : BES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3967/bes2015.113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Expression of Estrogen Receptor Subtypes in Prolactinomas and Their Relationship to Tumor Biological Behavior.
Dopamine agonists (DA) are a first-line therapy for prolactinomas (PA). However, nearly 10% of prolactinomas do not respond to DA therapy. A considerable number of studies have shown that estrogen plays an important role in the development of prolactinomas. However, the expression of estrogen receptors (ER) in prolactinomas has not been fully explored. Accordingly, we examined the levels of ESR1 and its subtypes Δ5-Del-ESR1 and ESR2 mRNA in prolactinomas. In the present study, we found that ESR1 mRNA levels were significantly lower in women of childbearing age group compared to men (P
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
